Your browser doesn't support javascript.
loading
Global progress toward the elimination of active trachoma: an analysis of 38 countries.
Renneker, Kristen K; Abdala, Mariamo; Addy, James; Al-Khatib, Tawfik; Amer, Khaled; Badiane, Mouctar Dieng; Batcho, Wilfrid; Bella, Lucienne; Bougouma, Clarisse; Bucumi, Victor; Chisenga, Tina; Dat, Tran Minh; Dézoumbé, Djore; Elshafie, Balgesa; Garae, Mackline; Goepogui, André; Hammou, Jaouad; Kabona, George; Kadri, Boubacar; Kalua, Khumbo; Kanyi, Sarjo; Khan, Asad Aslam; Marfo, Benjamin; Matendechero, Sultani; Meite, Aboulaye; Minnih, Abdellahi; Mugume, Francis; Olobio, Nicholas; Omar, Fatma Juma; Phiri, Isaac; Sanha, Salimato; Sharma, Shekhar; Seife, Fikre; Sokana, Oliver; Taoaba, Raebwebwe; Tesfazion, Andeberhan; Traoré, Lamine; Uvon, Naomi; Yaya, Georges; Logora, Makoy Yibi; Hooper, P J; Emerson, Paul M; Ngondi, Jeremiah M.
Afiliação
  • Renneker KK; International Trachoma Initiative, The Task Force for Global Health, Decatur, GA, USA. Electronic address: krenneker@taskforce.org.
  • Abdala M; Mozambique Ministry of Health, Maputo, Mozambique.
  • Addy J; Ghana Ministry of Health, Accra, Ghana.
  • Al-Khatib T; Yemen Ministry of Health, Sana'a, Yemen.
  • Amer K; Egypt Ministry of Health, Cairo, Egypt.
  • Badiane MD; Senegal Ministry of Health, Dakar, Senegal.
  • Batcho W; Benin Ministry of Health, Porto Nova, Benin.
  • Bella L; Cameroon Ministry of Health, Yaounde, Cameroon.
  • Bougouma C; Burkina Faso Ministry of Health, Ouagadougou, Burkina Faso.
  • Bucumi V; Burundi Ministry of Health, Bujumbura, Burundi.
  • Chisenga T; Zambia Ministry of Health, Lusaka, Zambia.
  • Dat TM; Vietnam Ministry of Health, Hanoi, Vietnam.
  • Dézoumbé D; Chad Ministry of Health, N'Djamena, Chad.
  • Elshafie B; Sudan Ministry of Health, Khartoum, Sudan.
  • Garae M; Vanuatu Ministry of Health, Port Vila, Vanuatu.
  • Goepogui A; Guinea Ministry of Health, Conakry, Guinea.
  • Hammou J; Morocco Ministry of Health, Rabat, Morocco.
  • Kabona G; Tanzania Ministry of Health, Dodoma, Tanzania.
  • Kadri B; Niger Ministry of Health, Niamey, Niger.
  • Kalua K; Malawi Ministry of Health, Lilongwe, Malawi.
  • Kanyi S; The Gambia Ministry of Health, Banjul, The Gambia.
  • Khan AA; Pakistan Ministry of Health, Islamabad, Pakistan.
  • Marfo B; Ghana Ministry of Health, Accra, Ghana.
  • Matendechero S; Kenya Ministry of Health, Nairobi, Kenya.
  • Meite A; Côte d'Ivoire Ministry of Health, Abidjan, Côte d'Ivoire.
  • Minnih A; Mauritania Ministry of Health, Nouakchott, Mauritania.
  • Mugume F; Uganda Ministry of Health, Kampala, Uganda.
  • Olobio N; Nigeria Ministry of Health, Abuja, Nigeria.
  • Omar FJ; Zanzibar Ministry of Health, Zanzibar Town, Zanzibar.
  • Phiri I; Zimbabwe Ministry of Health, Harare, Zimbabwe.
  • Sanha S; Guinea-Bissau Ministry of Health, Bissau, Guinea-Bissau.
  • Sharma S; Nepal Ministry of Health, Kathmandu, Nepal.
  • Seife F; Ethiopia Ministry of Health, Addis Ababa, Ethiopia.
  • Sokana O; Solomon Islands Ministry of Health, Honiara, Solomon Islands.
  • Taoaba R; Kiribati Ministry of Health, Tarawa, Kiribati.
  • Tesfazion A; Eritrea Ministry of Health, Asmara, Eritrea.
  • Traoré L; Mali Ministry of Health, Bamako, Mali.
  • Uvon N; DR Congo Ministry of Health, Kinshasa, DR Congo.
  • Yaya G; Central African Republic Ministry of Health, Bangui, Central African Republic.
  • Logora MY; South Sudan Ministry of Health, Juba, South Sudan.
  • Hooper PJ; International Trachoma Initiative, The Task Force for Global Health, Decatur, GA, USA.
  • Emerson PM; International Trachoma Initiative, The Task Force for Global Health, Decatur, GA, USA.
  • Ngondi JM; RTI International, Washington, DC, USA.
Lancet Glob Health ; 10(4): e491-e500, 2022 04.
Article em En | MEDLINE | ID: mdl-35303459
BACKGROUND: Global elimination of trachoma as a public health problem was targeted for 2020. We reviewed progress towards the elimination of active trachoma by country and geographical group. METHODS: In this retrospective analysis of national survey and implementation data, all countries ever known to be endemic for trachoma that had either implemented at least one trachoma impact survey shown in the publicly available Trachoma Atlas, or are in Africa were invited to participate in this study. Scale-up was described according to the number of known endemic implementation units and mass drug administration implementation over time. The prevalence of active trachoma-follicular among children aged 1-9 years (TF1-9) from baseline, impact, and surveillance surveys was categorised and used to show programme progress towards reaching the elimination threshold (TF1-9 <5%) using dot maps, spaghetti plots, and boxplots. FINDINGS: We included data until Nov 10, 2021, for 38 countries, representing 2097 ever-endemic implementation units. Of these, 1923 (91·7%) have had mass drug administration. Of 1731 implementation units with a trachoma impact survey, the prevalence of TF1-9 had reduced by at least 50% in 1465 (84·6%) implementation units and 1182 (56·4%) of 2097 ever-endemic implementation units had reached the elimination threshold. 2 years after reaching a TF1-9 prevalence below 5%, most implementation units sustained this target; however, 58 (56·3%) of 103 implementation units in Ethiopia showed recrudescence. INTERPRETATION: Global elimination of trachoma as a public health problem by 2020 was not possible, but this finding masks the great progress achieved. Implementation units in high baseline categories and recrudescent TF1-9 might prolong the attainment of elimination of active trachoma. Elimination is delayed but, with an understanding of the patterns and timelines to reaching elimination targets and a commitment toward meeting future targets, global elimination can still be achieved by 2030. FUNDING: None.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tracoma / Doenças do Recém-Nascido Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans / Infant / Newborn País/Região como assunto: Africa Idioma: En Revista: Lancet Glob Health Ano de publicação: 2022 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tracoma / Doenças do Recém-Nascido Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Child / Child, preschool / Humans / Infant / Newborn País/Região como assunto: Africa Idioma: En Revista: Lancet Glob Health Ano de publicação: 2022 Tipo de documento: Article País de publicação: Reino Unido